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Abstract: We reviewed 143 papers that described the relationship between moderate drinking 
of alcohol and some aspect of cognition. Two types of papers were found: (1) those that provided 
ratios of risk between drinkers and nondrinkers (74 papers in total) and (2) those that, although they 
did not provide such ratios, allowed cognition in drinkers to be rated as “better,” “no different,” or 
“worse” than cognition in nondrinkers (69 papers in total). The history of research on moderate 
drinking and cognition can be divided into two eras: 1977–1997 and 1998–present. Phase I 
(1977–1997) was the era of neuropsychological evaluation involving mostly young to middle-
aged (18–50 years old) subjects. Although initial studies indicated moderate drinking impaired 
cognition, many later studies failed to confirm this, instead finding no difference in cognition 
between drinkers and nondrinkers. Phase II (1998–present) was and is the era of mental status 
exam evaluation involving mostly older ($55 years old) subjects. These studies overwhelmingly 
found that moderate drinking either reduced or had no effect on the risk of dementia or cognitive 
impairment. When all the ratios of risk from all the studies in phase II providing such ratios are 
entered into a comprehensive meta-analysis, the average ratio of risk for cognitive risk (dementia 
or cognitive impairment/decline) associated with moderate “social” (not alcoholic) drinking of 
alcohol is 0.77, with nondrinkers as the reference group. The benefit of moderate drinking applied 
to all forms of dementia (dementia unspecified, Alzheimer’s disease, and vascular dementia) and 
to cognitive impairment (low test scores), but no significant benefit against cognitive decline (rate 
of decline in test scores) was found. Both light and moderate drinking provided a similar benefit, 
but heavy drinking was associated with nonsignificantly higher cognitive risk for dementia and 
cognitive impairment. Although the meta-analysis also indicated that wine was better than beer 
or spirits, this was based on a relatively small number of studies because most studies did not 
distinguish among these different types of alcohol. Furthermore, a number of the studies that did 
make the distinction reported no difference among the effects of these different types of alcohol. 
Therefore, at present this question remains unanswered. Analysis also showed that the presence 
of the apolipoprotein E epsilon 4 allele eliminated the benefit of moderate drinking. However, 
this was based on a relatively small number of studies and several other studies have found a 
beneficial effect of the epsilon e4 allele. Further studies are necessary to settle this question. The 
benefit of moderate alcohol for cognition was seen in both men and women, although the amount 
and pattern of drinking is very different between the two sexes. Lastly, the finding of unaffected 
or significantly reduced cognitive risk in light to moderate drinkers was seen in 14/19 countries 
for which country-specific ratio data were available, with three of the five remaining countries 
showing nonsignificant reductions as well. Overall, light to moderate drinking does not appear 
to impair cognition in younger subjects and actually seems to reduce the risk of dementia and 
cognitive decline in older subjects.
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Introduction
What is the effect of moderate “social” (not alcoholic) 
drinking of alcohol on cognition? Does it impair cognition? 
Does it have no effect on cognition? Or does it enhance 
or preserve cognition? We have reviewed and analyzed 
results from studies from the late 1970s through June 
of 2011, comparing cognitive risk (including dementia, 
cognitive impairment, and cognitive decline) in moderate 
social drinkers (not alcoholics) with cognitive risk in 
nondrinkers.
Our interest in this topic arose from our finding that 
6 days of moderate alcohol exposure protects rat organotypic 
hippocampal-entorhinal cortex brain slice cultures from the 
toxicity of amyloid-β,1 the protein that has been strongly 
implicated in the pathogenesis of Alzheimer’s disease (AD).2 
We3–6 and others7,8 have hypothesized a mechanism in which 
alcohol “protects” by its “preconditioning” effect on neu-
rons and glia, which involves upregulation of heat shock 
proteins and other cellular pro-survival mechanisms such as 
N-methyl-D-aspartate receptors, protein kinase C epsilon, 
and focal adhesion kinase. This line of research naturally led 
us to inquire whether there was any evidence that drinking 
alcohol may “protect” from AD and other forms of dementia 
or cognitive impairment. There was a large scientific literature 
addressing this question9–17 and our attempt to understand this 
literature led us to write this review.
Methods
Search strategies
The collection of studies reviewed here was assembled 
primarily by manual search using the bibliographies of each 
paper and was supplemented by literature searches using the 
PubMed database. Search terms used for database searches 
included alcohol or ethanol, dementia, AD, cognition, mild 
cognitive impairment (MCI), cognitive decline, and memory, 
all in various combinations. In addition, these terms were also 
combined with the names of more than 250 countries around 
the world. This strategy yielded studies providing ratios of 
risk from 19 countries (Australia, Brazil, Canada, China 
and Taiwan, Denmark, Finland, France, Germany, Greece, 
Hungary, Italy, Japan, Korea, the Netherlands, Nigeria, Spain, 
Sweden, the UK, and the US). Two additional countries 
(Ireland and Norway) were added to this list from “non-ratio” 
studies. (The total number increased by eleven if countries 
included in the Syst-Eur study18 were added [Belgium, 
Bulgaria, the Czech Republic, Estonia, Israel, Lithuania, 
Poland, Portugal, Romania, the Russian Federation, and 
Slovakia], but in this study it was not possible to associate 
any particular country with its results.)
Unfortunately, studies in languages other than English 
were not reviewed. In addition, there is no doubt that the 
search missed some studies for a variety of reasons, and we 
apologize for these omissions.
Two types of studies
Two types of studies are distinguished in this review: 
(1) those providing ratios of risk, such as odds ratios (ORs), 
risk ratios (RRs), or hazard ratios (HRs) (collectively 
termed “XRs”); and (2) those that, instead of providing 
such ratios, could be interpreted in terms of whether some 
aspect of cognition was “worse,” “no different,” or “better” 
in moderate drinkers than in nondrinkers. Historically, the 
studies without ratios preceded those with ratios, and so that 
is the order of presentation.
Studies without ratios of risk
There were 69 studies without ratios of risk that could have 
results grouped into categories of (1) worse, (2) no different, 
and (3) better cognition in drinkers than in nondrinkers, or 
in heavy drinkers than in light drinkers. The data in these 
three categories were plotted as cumulative sum histograms 
of the numbers of studies accumulating each year from 1975 
to 2011. (A cumulative sum is a sequence of partial sums 
of a given sequence; for example, the cumulative sums of 
the sequence 1,2,1 are 1,3,4.) These histogram plots provide 
valuable information on the history of the field, including 
when studies in each category occurred and for how long and 
at what rate they continued to accumulate in each category. 
Data concerning the type of cognitive testing employed and 
the age of the subjects in the studies are also plotted.
Studies with ratios of risk
There were 74 studies that provided various ratios of risk, 
including ORs, RRs, or HRs. Such numbers allowed for 
relatively direct comparisons among studies and were used 
for meta-analysis. The XRs were pooled and plotted together 
in forest plots because such ratios are roughly equivalent 
when describing events such as AD or MCI that are relatively 
rare or uncommon.19–22
The present review does not follow what has become 
the conventional method for meta-analysis in which only 
a subset of studies that meet certain criteria for quality are 
selected for analysis from a larger set of studies collected in 
a field.23–25 Instead, and perhaps closer to the original concept Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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of meta-analysis, which called for liberal inclusion criteria 
that incorporate “all studies, good bad and indifferent”26 and 
for considering the unit of analysis to be all the findings from 
each study and not just one summary value for each study,26 
we chose to “uncritically” collect data from as many studies 
as possible and thus present the “big picture,” both for its own 
value and as a complement and a context for more restricted 
or selective meta-analyses. Therefore, if a study reported 1 OR 
or 50, all were included in the analysis. The second reason is 
that several meta-analyses of the effects of moderate drinking 
on cognition that employed the conventional, more restricted 
sample method have recently been published.11,12
The normal meta-analysis method of presenting a forest 
plot and calculating an overall ratio with its 95% confidence 
intervals (CIs) was followed. Since such an “uncritical” meta-
analysis includes the effects of moderate drinking on a broad 
spectrum of cognitive function – including dementia, cognitive 
impairment, and cognitive decline – and different methods of 
measuring cognition, the presence of significant “heterogeneity” 
or inconsistency among studies27–29 was determined. This was 
achieved by calculating the P-value (Qp) of the Q statistic (the 
weighted sum of squared differences between individual study 
effects and the pooled effect across studies) and the percentage 
of variability due to heterogeneity rather than chance (I2); these 
two numbers are reported in the forest plot figures and com-
mented on in the text. The results of a random-effects model 
are always reported in the forest plots on the left-hand side of 
the figures. On the right-hand side of the figures are found plots 
of the “approximately normal”30 distributions of the logs of the 
ratios (log[XR] values), along with the results of a fixed-  effects 
model. In addition, small inset quantile–quantile (Q–Q) plots of 
the log(XR) values are presented to better display any deviations 
from normality; small inset funnel plots are also presented, to 
aid detection of “publication bias.”31,32 The tops of the funnel 
plots are labeled with the P-values of two tests for funnel plot 
asymmetry, the regression test31 on the left and the rank correla-
tion test33 on the right.
The open-source R statistical program34 and its metafor 
package, which can be obtained from http://www.r-project.org 
and http://www.metafor-project.org, respectively, were used to 
carry out the statistical meta-analysis and generate the plots.
Results
Does moderate drinking affect  
cognitive risk?
Before answering this question, because the methods of 
measuring cognition and the ages of the subjects studied 
have changed in important ways since 1977, it is important 
to describe the history of research in this field. This history 
begins with studies without ratios of risk, since the early work 
did not provide such ratios.
Cognition in studies without ratios of risk
Figure 1 and Table 1 summarize the results from these 
69 studies, which included a total of 111,909 subjects 
(56,934 women and 54,906 men) and provided a total of 
87 judgments of whether cognition was worse, no different, 
or better in drinkers than in nondrinkers or in heavy drinkers 
than in light drinkers (there are more judgments than studies 
because some studies reported results for men and women 
separately). Of these 69 studies, 46 were from the US, 13 
from Europe (Denmark; Finland; France; the Netherlands; 
Ireland, Scotland, Norway; Sweden; and the UK), seven from 
Australia, two from Asia (China and Japan), and one from 
Canada. As seen in Figure 1, the 1977 study by Parker and 
Noble35 is considered the beginning of investigation of alco-
hol’s effect on cognition in social drinkers. It reported worse 
cognition in social drinkers that was related to the quantity of 
alcohol consumed per occasion; this study is labeled along 
the x-axis as the first element on the “Worse” histogram 
(heavy, solid gray line). These authors concluded that their 
results supported the “continuity hypothesis” of Ryback36 that 
proposed, as summarized by Parsons and Nixon, that “there 
is a continuum of alcohol effects on the brain, ranging from 
the profound memory and abstracting impairment found 
in patients with Korsakoff’s disease, through the moderate 
cognitive impairments found in non-Korsakoff alcoholics, to 
mild cognitive impairments that might be present in heavy 
to moderate social drinkers.”37 However, within a few years 
studies reporting no difference (“NoDiff” histogram; left, 
heavy black line) in cognition between drinkers and non-
drinkers began to appear, and such studies have continued 
to accumulate up to the present (43 studies in total), while 
the “Worse” histogram plateaued and eventually stopped 
accumulating in 2003 (only 14 studies in total). In 1998 a 
third histogram (right, heavy black line) of studies reporting 
“Better” cognition in moderate drinkers began accumulating 
more rapidly (one study reporting “better” was seen earlier, 
in 1987), and this has continued up to the present (30 stud-
ies in total).
Why did these studies finding “better” cognition in drinkers 
start appearing so late? There appear to be two reasons for 
the late appearance of better cognition in drinkers. First, 
more than 60% (18/29) of these “better” studies used some Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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type of mental status exam (thin dotted line labeled b+mse in 
Figure 1), such as the Mini-Mental State Examination (MMSE), 
the Telephone Interview for Cognitive Status™ (TICS™), the 
TELE telephone interview, the Modified Mini-Mental State (3MS) 
examination, or the Cognitive Abilities Screening Instrument. 
Only one study employed a mental status exam before 1998; 
therefore, the history of studies of alcohol and cognition 
in social drinkers (not alcoholics) can be divided into two 
phases, with phase II (1998–2011) being the “mental status” 
era, as labeled in Figure 1. Phase II is also characterized by 
more studies of older subjects ($55 years old, thin dashed 
line labeled gte55 in Figure 1) than in phase I.
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Figure 1 Cumulative sum histograms (heavy lines) of numbers of studies that did not report various ratios or risk but instead reported “worse” (heavy solid gray line), 
“NoDiff” (left, heavy solid black line), or “Better” (right, heavy solid black line) cognition in “social” drinkers (not alcoholics) versus nondrinkers from 1975 to 2011. Thin 
dotted line at the lower right plots the cumulative sum histogram for studies that reported better cognition and used a MSe to evaluate cognition (b+mse). Thin dashed line 
plots the cumulative sum histogram for studies of subjects who were $55 years of age (gte55). Dashed vertical line at 1998 separates two phases of research on this question 
(phase i: neuropsychology; phase ii: mental status). inset table shows the breakdown by country of studies reporting worse, no different, or better cognition in drinkers.
Abbreviations: CI, confidence interval; b, better; ge55, $55 years of age; HR, hazard ratio; MSe, mental status exam; NoDiff, no different; OR, odds ratio; RR, risk ratio; 
UK, United Kingdom; USA, United States of America.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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Table 1 Cognitive performance in drinkers in “non-ratio” studies, 1977–1986, 1986–1996, and 1997–present
1977–1986 (n = 17)
Worse (8/17 = 47%) No difference (9/17 = 53%) Better (0/16 = 0%)
Parker and Noble35: 102 m Parker et al40: 544 f
Parker et al40: 481 m Parker et al43: 21 m, 60 f
Parker et al44: 45 m Birnbaum et al45: 93 f
Jones and Jones46: 32 f Cala et al47: 24 m, 15 f
Macvane et al48: 106 m Hannon et al49: 67 m, 103 f
Hannon et al50: 40 m Bergman51: 192 f
Hannon et al50: 52 f Hunt et al52: 41 m, 39 f
Bergman51: 195 m Parsons53: 100 m
Jones-Saumty and Zeiner54: 80 mf
1986–1996 (n = 18)
Worse (4/18 = 22%) No difference (12/18 = 67%) Better (2/18 = 11%)
Parker et al39: 481 m, 544 f Carey and Maisto56: 85 f Farmer et al57: 834 m, 1198 f
Martin et al55: 119 m, 134 f Page and Cleveland58: 322 m Nichols et al59: 22 m
Mangione et al60: 190 m, 282 f Bowden61: 23 m, 17 f
Fox et al62: 26 m, 5 f Goodwin et al63: 124 m, 146 f
emmerson et al64: 80 m
Alterman and Hall65: 95 m
waugh et al66: 131 m
Bates and Tracy67: 654 m, 654 f
Salamé68: 72 m
Scherr et al69: 1382 m, 2241 f
Arbuckle et al70: 140 m
Christian et al71: 4739 m
1997–present (n = 52)
Worse (1/52 = 2%) No difference (20/52 = 38%) Better (28/52 = 54%)
Schinka et al41: 230 mf Seux et al18: 751 m Seux et al18: 1474 f
Schinka et al42: 176 m, 209 f Cerhan et al73: 6156 m
Carmelli et al72: 566 m Cerhan et al73: 7711 f
Dent et al74: 209 m elias et al77: 1053 f
Broe et al75: 155 m, 162 f Bond et al79: 808 m
Nixon76: 37 m, 3 f Bond et al79: 1028 f
elias et al77: 733 m Kalmijn et al80: 989 f
Sands et al78: 8080 f Leroi et al82: 942 f
elwood et al81: 1649 m wang et al83: 1058 m, 1520 f
Kalmijn et al80: 905 m Bond et al84: 1856 m
Leroi et al82: 546 m Bond et al84: 2551 f
Reid et al85: 232 m, 569 f Zimmerman et al87: 182 f
Schinka et al86: 3361 m Lindeman et al88: 438 m, 389 f
Krahn et al89: 2984 m Yonker et al90: 1152 f
Krahn et al89: 3453 f Rodgers et al91: 3122 m
Yonker et al90: 1072 m Rodgers et al91: 3281 f
Richards et al92: 861 f Richards et al92: 903 m
Stott et al93: 1804 m Reid et al94: 760 m
Cooper et al95: 684 m, 1051 f McDougall et al96: 60 m
Andersen et al97: 1466 m, 1833 f Ngandu et al98: 506 m, 835 f
Caspers et al99: 118 m Lang et al100: 3409 m
Caspers et al99: 169 f Lang et al100: 3877 f
Sabia et al101: 4073 m Stott et al93: 3000 f
Townsend et al102: 1698 f
Xu et al103: 176 m
Arntzen et al104: 2227 m
Arntzen et al104: 2806 f
Yamazaki et al105: 130 m, 110 f
Notes: First section covers 17 studies without ratios from 1977 to 1986, reviewed by Parsons.38 second section covers 18 studies without ratios from 1986 to 1996, reviewed 
by Parsons and Nixon.37 Third section covers 52 studies without ratios from 1997 to the present. Some studies provide separate results for men (m) and women (f).Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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During phase I (1977–1997), in contrast, the studies 
measured various aspects of cognition primarily by a wide 
variety of neuropsychological tests, such as the Shipley 
Institute of Living Scale, the Wechsler Adult Intelligence Scale, 
the Wisconsin Card Sorting Test, various components of the 
Halstead–Reitan Neuropsychological Test Battery such as 
the Trail Making Test or the Category Test, the Stroop Color-
Word Test, and others. For this reason, phase I is labeled as 
“Neuropsychology” in Figure 1. The results of phase I studies 
of the relationship between social drinking and cognition were 
summarized in two reviews authored by Parsons, one in 198638 
and the other, authored with Nixon, in 1998.37 The earlier 
review concluded that “there are no stable or reproducible 
specific relationships” between drinking and performance on 
certain cognitive-perceptual tests and that “the results of studies 
to date are inconclusive.”38 The later review concluded that 
“heavy social drinkers had significantly worse performance on 
one or more cognitive tests than the light drinkers,” supporting 
the alcohol-causal-threshold hypothesis that “persons drinking 
five or six US standard drinks per day over extended time 
periods manifest some cognitive inefficiencies.” Therefore, 
light to moderate drinking was not consistently associated with 
any cognitive deficits, although the evidence continued to be 
“fragmentary and in need of replication.”37 This conclusion 
is further supported by the reanalysis by Parker et al39 of 
their earlier study.40 The reanalysis found that the cognitive 
deficits they had reported earlier were due to the effects of 
heavy drinkers (almost daily consumption of four drinks), 
since in lighter drinkers (two drinks/occasion, 1.6 times/week) 
“neither the quantity of alcohol consumed per occasion nor the 
frequency of consumption significantly predicted abstraction 
performance.”39
Table 1 lists the various studies that were included in 
Figure 1. The first and second sections of the table list studies 
during phase I, as discussed. The third section of Table 1 covers 
the period from 1997 to the present. Note that only 1/52 (2%) 
studies during this period found that social drinkers were 
cognitively worse than nondrinkers. In that study, of 230 male 
and female elderly African-Americans, Schinka et al41 reported 
that “medium intensity” (30–60 drinks/month) moderate 
drinkers (n = 25) had poorer general cognitive performance 
(3MS, Hopkins Verbal Learning Test, and Stroop test) than 
both nondrinkers (n = 116) and “high intensity” (.119 drinks/
month) heavy drinkers (n = 18). However, the same study’s 
hierarchical multiple regression analysis found drinking 
significantly “explained” variance in general cognition (2.4%), 
memory (4.8%), and executive function (4.9%), and the 
overall influence was beneficial or “facilitatory” – ie, drinking 
improved scores. Therefore, although listed in Table 1 in the 
“Worse” column, this study could also have been listed under 
“Better.” Furthermore, Schinka et al41 point out their study is 
inconsistent with their own work using identical methods to 
study an elderly, mostly white sample42 in which no significant 
effects of drinking or drinking intensity on cognition were seen. 
Shifting to the other categories, in 20/52 (38%) of the studies 
no difference was seen between drinkers and nondrinkers, and, 
in contrast to earlier research, better cognitive performance 
was seen in 28/52 (54%) of the studies. Many of these studies 
reporting better cognition in drinkers used mental status exams 
to evaluate cognition and also studied older ($55 years old) 
subjects.
In summary, when “no ratio” studies are reviewed, it 
appears that, when evaluated by standard psychological tests 
in younger subjects (,55 years old), heavy drinking (4–6 
drinks/day) is associated with cognitive impairment (the 
alcohol-causal-threshold hypothesis). However, there is no 
significant difference in cognition between light to moder-
ate drinkers and nondrinkers. Interestingly, when various 
mental status exams are used to assess cognition, it appears 
that drinkers have a reduced risk of dementia or cognitive 
impairment compared with nondrinkers.
Cognition in studies with ratios of risk
As seen in the forest plot in Figure 2A and in Table 2, the 
74 studies with ratios provided 446 ratios of risk (XRs) 
and included 253,791 subjects, including 173,970 women 
and 122,033 men. For 68 studies (92%), the subjects 
were aged $55 years, while for 52 studies (70%) the 
subjects were aged $65 years. About 87% of the ratios 
(388/446) were derived from studies that employed mental 
status exams as all or part of the measure of cognition. 
Eighty percent of these studies took place since 1998 and 
therefore can be considered part of the phase II mental sta-
tus era. Of these 74 studies, 30 were from the US, 25 from 
Europe   (Denmark, Finland, France, Germany, Greece, the 
  Netherlands, Hungary, Italy, Spain, Sweden, and the UK), 
eight from Asia (China, Japan, Korea, and Taiwan), three from 
Australia, five from Canada, two from Africa (Nigeria), and 
one from South America (Brazil).
As seen in Figure 2A, the overall weighted mean 
value (XRwm) from a random-effects meta-analysis was 
0.77, and the 95% CI was relatively narrow (0.73–0.80), 
showing a significantly reduced risk for dementia, cognitive 
impairment, or cognitive decline in the drinkers. Significant Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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heterogeneity was present (I2 = 83.1%; Qp = 0.0000). Since 
it is the log(XR) values that have an approximately normal 
distribution,30 Figure 2B shows a histogram and smoothed 
(solid line) plot of all log(XR) values. Although both low 
and high ends of log(XR) distribution diverge slightly from 
normal compared with a pure normal distribution created 
with the same mean and variance (dashed line), the plot 
illustrates nonetheless that the log(XR) distribution is close 
to normal, with a mean of −0.278. This normality is also 
seen in the small inset normal Q–Q plot at the lower left of 
the figure. The funnel plot at the lower right was relatively 
symmetric and did not indicate publication bias. Taking the 
antilog of the mean gives an XRm of 0.76 (almost identical 
to that seen for the weighted average random-effects analy-
sis) with a relatively narrow 95% CI (0.71–0.81), showing 
a significant reduction in cognitive risk in drinkers. The 
basic normality of the log(XR) distribution is consistent 
with it being close to the actual population distribution; 
therefore, it shows a real and beneficial effect of light to 
moderate drinking that reduces the risk of dementia, cog-
nitive impairment, and cognitive decline in older adults 
by 20%–25%.
Does it make any difference if the reference group  
of nondrinkers includes former drinkers, who might 
be considered “sick quitters”?
One criticism of studies reporting lower risk or better   outcome 
in light to moderate drinkers is that the reference group of 
nondrinkers or nondrinkers includes former drinkers who 
might be considered “sick quitters”; this may bias the results 
by   making the reference group “sicker” than it really is and, 
by comparison, make drinkers appear better off than they really 
are.179–183 However, Figure 3 shows that 19 studies with 191 
ratios excluded former drinkers from the reference group and 
still found a protective effect of drinking (XRwm = 0.79 [95% 
CI: 0.75–0.84]; XRm = 0.72 [95% CI: 0.66–0.80]).
RE Model
XR = OR, RR, HR (log scale)
(N  = 446, 74 studies)
Qp = 0.0000
I2 = 83.1%
All: XRwm = 0.77 (0.73, 0.80)
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Figure 2 (A) Forest plot of all 446 XRs (white dots) plus or minus their 95% Cis (horizontal “whiskers”) from 74 studies providing ratios; ratios are listed in order from 
smallest to largest. XRwm is the weighted (wt = 1/SeM2) mean of all 446 ratios from a random-effects meta-analysis model with 95% Ci in parentheses. Mean value ±95% 
CI is to the left of and significantly less than the thick solid vertical line at 1.00 that denotes no difference; this value indicated on the plot’s x axis with ±95% Ci (vertical 
dashed lines). (B) Histogram of the probability density of the log(XR) values with a superimposed smooth probability density curve (solid line) and a superimposed normal 
distribution density curve (dashed line) calculated using the mean and variance of log(XR). XRm is the simple (not weighted) antilog of the mean of all log(XR) values with 
the 95% CI in parentheses; this value indicated on the plot’s x axis with ±95% Ci (vertical dashed lines). Small inset graph on left is a normal Q–Q plot showing normality 
and departures from normality of the log(XR) distribution. Small inset graph on right is funnel plot with P-values for regression (left) and rank correlation (right) tests for 
asymmetry across top. Note that XRm is identical to XRwm.
Abbreviations: CI, confidence interval; HR, hazard ratio; NoQuitters, no quitters; OR, odds ratio; Q–Q, quantile–quantile; RR, risk ratio; SEM, standard error of the mean; 
wt, weight; XRs, hazard ratios, odds ratios, and risk ratios; XRwm, weighted mean ratio.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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Table 2 The 74 studies providing ratios of risk listed by decade
1980s (n = 4) 1990s (n = 14) 2000s (n = 53)
Heyman et al106 Hofman and van Duijn107 Cervilla et al108
French et al109 iliffe et al110 Commenges et al111
Amaducci et al112 Hebert et al113 Galanis et al114
Guralnik and 
Kaplan115
ensrud et al116
Yoshitake et al118
Hébert et al117
Tyas et al119
Hendrie et al120 DeCarli et al121
Launer et al122 Zuccala et al123
Dufouil et al124 Huang et al125
Orgogozo et al126 Lindsay et al127
Tsolaki et al128 Ruitenberg et al129
edelstein et al130 Tanaka et al131
Carmelli et al132 Truelsen et al133
Harwood et al134 Bachman et al (USA)135
Leibovici et al136 Bachman et al (Nigeria)135
Mukamal et al137
Zhou et al138
Anttila et al139
Britton et al140
Larrieu et al141
Luchsinger et al142
espeland et al143
Ganguli et al144
Järvenpää et al145
Rozzini and Trabucci146
Stampfer et al147
Dai and Pruett148
Deng et al149
Ogunniyi et al151
Simons et al152
wright et al153
Yip et al154
McGuire et al155
Solfrizzi et al156
vincze et al157
wadley et al158
Kivipellto et al159
Mehlig et al160
Umegaki et al161
Barnes et al162
Cherbuin et al163
Peters et al164
Sabia et al165
Yaffe et al166
Chan et al167
Garcia et al168
Lobo et al169
Lopes et al170
Luck et al171
Smith et al172
virtaa et al173
Yen et al174
Au Yeung et al175
Gureje et al150
Kim et al176
Rusanen et al177
weyerer et al178
Note: Most (about 80%) of the studies took place after 1998 in the mental status era.
For example, Hendrie et al120 used lifetime nondrinkers 
as the reference group, thereby avoiding former drinkers. 
Zuccala et al123 attempted to compensate for the presence of 
sick quitters in the reference group of nondrinkers by adjusting 
for a comorbidity covariate. Ruitenberg et al129 reported that the 
HR for dementia in light to moderate drinkers when subjects 
with changed drinking patterns were excluded was 0.57 (95% 
CI: 0.36–0.89), which is virtually the same as the HR of 0.58 
(95% CI: 0.38–0.90) when they were not excluded. Mukamal 
et al137 did not include either former drinkers or quitters in his 
reference group of nondrinkers, noting that “former drinkers 
and quitters had approximately 20% to 60% higher odds of 
dementia than long-term nondrinkers.” Anttila et al139 found 
an OR of 0.48 (95% CI: 0.24–0.95) for cognitive impairment 
in infrequent drinkers when compared with a reference group 
of “never” drinkers that did not include former drinkers. 
The ORs for poor cognitive performance from the study of 
Britton et al140 used a reference group of those who reported 
drinking within the past year but not in the past week, thereby 
avoiding questions associated with comparisons between 
former drinkers and nondrinkers. Similarly, when Ganguli 
et al144 compared the minimal drinking group with life-long 
nondrinkers (excluding quitters), the lower odds of decline on 
the MMSE of 0.05 (95% CI: 0.01–0.26) remained significant; 
this also was seen for the ratio for the moderate drinking 
group for decline on the MMSE of 0.27 (95% CI: 0.09–0.84). 
Stampfer et al147 excluded former drinkers or drinkers whose 
consumption greatly declined from the reference group of 
nondrinkers. Wright et al153 distinguished past drinkers from 
“never drinkers” and only included the latter in their reference 
group; likewise, Yip et al154 used never drinkers as the reference 
category. The HRs from Solfrizzi et al156 showing a lower 
hazard of progression from MCI to dementia in light drinkers 
of alcohol of 0.15 (95% CI: 0.03–0.78) and light drinkers of 
wine of 0.15 (95% CI: 0.03–0.77) used a nondrinkers reference 
group from which former drinkers were excluded. Wadley 
et al158 used life-long nondrinkers as the reference group. The 
reduced HR for dementia of 0.56 (95% CI: 0.38–0.82) in 
female wine drinkers seen in the study by Mehlig et al160 was 
maintained when former drinkers were included as drinkers 
rather than as nondrinkers. Lobo et al169 excluded former 
drinkers from the reference group of nondrinkers.
is there any common factor in the ratios that 
showed significantly worse cognition in drinkers?
Of the   446 ratios in Figure   2, 123 (28%) were significantly 
less than 1, indicating less  risk or “better” cognition in 
drinkers; 300 (67%)  were not significantly different than 1, Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
Dovepress 
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indicating no difference in risk for drinkers and nondrinkers 
(“NoDiff”); and only 23 (5%) were significantly greater 
than 1, indicating greater risk or “worse” cognition in 
drinkers. These 23 ratios from 18 studies are plotted in Fig-
ure 4 and will be discussed in detail.
Of the 23 ratios in the “worse” group, twelve were associ-
ated with heavy drinking, including three (1.58, 1.59, 1.93) 
for cognitive impairment from Zuccala et al123 in which sub-
jects consumed more than 1 L/day of wine. The ratio of 1.80 
for cognitive decline from the study in Hungary by Vincze 
et al157 was for “regular” (heavy) drinkers. The ratios of 2.40 
for cognitive decline and 3.90 for dementia from a Finnish 
study by Järvenpää et al145 were both for heavy binge drinkers. 
The ratio of 2.50 for AD from Harwood et al134 was for white 
non-Hispanic subjects in the US consuming more than two 
drinks/day, which was considered heavy drinking. The ratio 
of 4.01 from the study in the US by Edelstein et al130 was for 
women drinking two drinks/day, which is considered heavy 
for women. The ratio of 4.99 from the study in China by Chan 
et al167 was from heavy drinkers (.4 drinks/day). The ratio of 
6.09 from the study by Barnes et al162 was for heavy drinkers 
(.2 drinks/day). The ratios of 7.07 for dementia from Anttila 
et al139 and 7.42 for dementia from Kivipelto et al159 were from 
subjects in Finland drinking frequently, often in binges, who 
also had the apolipoprotein E epsilon 4 (APOE ε4) allele. 
Lastly, although not related to heavy drinking, the ratio of 
3.28 for AD was from subjects in the Canadian Study on 
Health and Aging127 with the APOE ε4 allele.
The remaining worse ratios were not clearly associated 
with heavy or binge drinking. The ratio of 1.46 for cognitive 
impairment from the study in China by Au Yeung et al175 was 
for light drinkers, and the same study also reported a ratio of 
1.53 for ex-drinkers. The ratio of 2.34 for dementia from the 
study by Truelsen et al133 in Denmark was for beer drinkers 
compared with subjects who never or hardly ever drank beer. 
Similarly, the ratio of 2.47 for dementia from the study in 
China by Deng et al149 was for light to moderate beer drink-
ers. The ratio of 3.39 for vascular dementia from Yoshitake 
et al118 was for a broad group of drinkers in Japan in which 
alcohol consumption was not quantified but simply categorized 
into nondrinkers and drinkers. The 3.47 ratio for cognitive 
impairment from the study in China by Zhou et al138 was for 
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Figure 3 (A) Forest plot of 191 XRs (white dots) plus or minus their 95% Cis (horizontal “whiskers”) from 19 studies providing ratios with a reference group that did not 
include former drinkers. (B) Histogram of the probability density of the log(XR) values with a superimposed smooth probability density curve (solid line) and a superimposed 
normal distribution density curve (dashed line) calculated using the mean and variance of log(XR).
Notes: The XRwm in Figure 3A is close to that seen in Figure 2. Other conventions are as for Figure 2.
Abbreviations: CI, confidence interval; HR, hazard ratio; NoQuitters, no quitters; OR, odds ratio; Q–Q, quantile–quantile; RR, risk ratio; SEM, standard error of the mean; 
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subjects consuming an unknown amount of alcohol daily; the 
same study reported a ratio of 1.71 for weekly consumption 
of an unknown amount of alcohol. The ratio of 4.17 for AD 
from the University of British Columbia cohort in the study 
in Canada by Tyas et al119 was for any amount of alcohol use. 
Finally, the ratio of 10.70 for AD from the study in France 
by Leibovici et al136 is for moderate wine drinkers in France 
only after adjustment for place of residence (community or 
institution); before adjustment the ratio was 0.13 (95% CI: 
0.04–1.02), suggesting reduced risk. The authors explained 
RE model
x
x
Worse: XRwm = 2.35 (1.94, 2.84)
Leibovici99-m-w-AD (DECO) -France
Kivipelto08-h-a-D (MMSE < = 24+) -Finland
Anttila04-h-bs- D( MMSE < = 24+) -Finland
Barnes09-h-a-D (3 MS + DSST) -USA
Chan10-h-a-CI (MMSE) -China
Tyas00-y-a-AD (NINCDS/ADRDA) -Canada
Edelstein98-h-a-CI (MMSE + 8T) -USA
Jarvenpaa05-b-a-D (TELE < 16) -Finland
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Figure 4 Forest plot of 23 XRs plus or minus their 95% CIs (horizontal “whiskers”) from 18 studies providing ratios where drinkers were significantly worse than 
nondrinkers.
Notes: Uppercase “H” at left of vertical reference line at 1 indicates ratios from heavy drinkers; “e4” indicates presence of apolipoprotein e epsilon 4 allele. Other 
conventions as in Figure 2A. Note that the XRwm of 2.43 (95% CI: 1.95–3.03) is much larger than that seen in Figure 2 and is significantly greater than 1.
Abbreviations: ♀, female; ♂, male; 3MS, Modified Mini-Mental State examination; 8t, 8 additional tests; AD, Alzheimer’s disease; ADL, Activities of Daily Living; AMT, 
Abbreviated Mental Test; CI, confidence interval; D, dementia; DECO, Deterioration Cognitive Observee test; DSST, Digit Symbol Substitution Test; HAMT, Hodkinson 
Abbreviated  Mental  Test;  HR,  hazard  ratio;  MMSe,  Mini-Mental  State  examination;  MSe,  mental  status  exam;  NiNCDS/ADRDA,  National  institute  of  Neurological 
Communicative Disorders and Stroke/Alzheimer’s Disease and Related Disorders Association criteria for AD;  NoDiff, no different; OR, odds ratio; RR, risk ratio; TELE, 
telephone screen for cognitive impairment; wDRT, word Delay Recall Test; XRs, hazard ratios, odds ratios, and risk ratios; XRwm, weighted mean ratio.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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this dramatic ratio change from 0.13 to 10.70 as due, at least 
in part, to demented and institutionalized residents being 
classed as nondrinkers due to drinking being forbidden in 
their facility and therefore inflating the number of AD cases 
in the nondrinkers group. Although this is a plausible explana-
tion, it has not been replicated in other studies that included 
institutionalization as a covariate. For example, Huang et al125 
reported an OR for AD of 0.5 (95% CI: 0.3–0.7) in light to 
moderate drinkers after adjusting for age, gender, education, 
smoking, institutionalization (living place), and baseline 
MMSE score. In addition, when institutionalized subjects 
were excluded and the analysis repeated, the results did not 
change significantly. In fact, the study by McCallum et al184 
reported that light to moderate alcohol significantly delayed 
the hazard of nursing home placement.
In summary, 13/23 ratios (57%) in the “worse” group were 
associated with either heavy drinking (12) or the APOE ε4 
allele (1). The remaining ten ratios linking light, moderate, or 
unknown amounts of alcohol consumption with significantly 
increased risk of dementia or cognitive impairment represent 
only 2.2% (10/446) of the total.
Other questions
Similar meta-analyses were done for a number of other 
questions, which will be discussed in reference to Figure 5, 
which presents a summary plot of the various meta-analyses 
carried out. As already discussed, comparing the lines labeled 
“All” and “Noquitter” in Figure 5 shows that there was no 
significant difference between the overall XRwm values of 
0.77 for “All” and 0.79 for no “sick quitters” in the reference 
group. In addition, the 23 ratios from 18 studies in the line 
in Figure 5 labeled “worse” have also been discussed in 
detail. (For reference, the overall XRwm values for “better” 
and “nodiff” groups of ratios are also presented; note that 
the overall weighted mean for “nodiff” of 0.88 was also 
significantly less than 1).
Does statistical adjustment for age, education,  
sex, and smoking change the effect of alcohol  
on cognitive risk?
Only including studies with these adjustments produced no 
significant change in alcohol’s effects, as seen for AdjAESK 
(0.75) in Figure 5.
Ratio of risk (drinkers/nondrinkers)
Female n = 80 (17) 0.69 (0.63, 0.77)
Male n = 81 (20) 0.74 (0.67, 0.83)
Noe4 n = 28 (10) 0.70 (0.58, 0.85)
e4 n = 28 (10) 0.89 (0.69, 1.15)
spirits n = 16 (8) 0.98 (0.84, 1.14)
Beer n = 27(11) 1.05 (0.86, 1.28)
Wine n = 62 (17) 0.77 (0.68, 0.87)
Heavy n = 93 (35) 1.12 (0.96, 1.30)
Mod n = 166 (54) 0.69 (0.64, 0.75)
Light n = 139 (36) 0.75 (0.71, 0.78)
CogDe n = 21 (7)  0.96 (0.76, 1.21)
CogImp n = 143 (31) 0.78 (0.73, 0.83)
VascDem n = 37 (7) 0.66 (0.52, 0.82)
AlzDem n = 98 (25) 0.73 (0.64, 0.82)
Dementia n = 145 (29) 0.77 (0.71, 0.83)
Worse n = 23 (18) 2.35 (1.94, 2.84)
nodiff n = 300 (64) 0.87 (0.85, 0.90)
Better n = 123 (43) 0.53 (0.50, 0.57)
NoMSE n = 43 (12) 0.80 (0.69, 0.91)
MSE n = 395 (58) 0.76 (0.72, 0.80)
xsect n = 91 (27) 0.78 (0.69, 0.87)
casecon n = 110 (14) 0.78 (0.71, 0.86)
cohort n = 245 (38) 0.76 (0.71, 0.80)
Adj AESK n = 309 (43) 0.75 (0.71, 0.79)
No quitter n = 191 (19) 0.79 (0.75, 0.84)
All n = 446 (74) 0.77 (0.73, 0.80)
Moderate drinking and risk of dementia or cognitive impairment/decline
0.00 0.25 0.50 0.75 1.00 1.25 1.50 2.00 2.50 3.00
Figure 5 Overall weighted mean ratios (XRwm) comparing cognitive function in drinkers and nondrinkers in the various groups analyzed. Group with number of ratios 
(number of studies) indicated on left; XRwm (95% confidence interval) given on right.
Note: See text for fuller description.
Abbreviations: AdjAESK, Adjusted for Age, Education, Sex, and Smoking; AlzDem, Alzheimer’s disease; casecon, case-control study; CogDec, cognitive decline; CogImp, cognitive 
improvement; e4, epsilon 4; heavy, heavy drinkers; light, light drinkers; mod, moderate drinkers; MSe, mental status exam; nodiff, no different; Noe4, no epsilon 4; NoMSe, no 
mental status exam; Noquitter, no quitters; vascDem, vascular dementia; XR, hazard ratio, odds ratio, and risk ratio; XRwm, weighted mean ratio; xsect, cross-sectional study.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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Are there any significant differences among 
longitudinal cohort studies, case-control studies,  
or cross-sectional studies?
There was no significant difference in alcohol’s effects when 
the three different types of epidemiological studies were 
considered separately, as seen for cohort (0.76), casecon 
(0.78), and xsect (0.78) in Figure 5.
Are there any significant differences between studies 
using mental status exams and those using other 
methods for measuring cognition?
There was no significant change in alcohol’s effects when 
cognition was measured in these two ways, as seen for MSE 
(0.76) and NoMSE (0.80) in Figure 5. However, note that 90% 
of the ratio studies used mental status exams in some way in 
their measurement of cognition, so this question must also be 
answered by referring to the discussion of the plot in Figure 1, 
which shows that mental status exams were more often asso-
ciated with finding “better” cognition in drinkers, while neu-
ropsychological tests were more often associated with finding 
“nodiff” in cognition between drinkers and nondrinkers.
Are there different effects of moderate drinking  
on general dementia, AD, and vascular dementia?
There were no significant differences between alcohol’s effects 
on the different types of dementia, as seen for Dementia (0.77), 
AlzDem (0.73), and VascDem (0.66) in Figure 5.
Are there specific effects of moderate drinking  
on cognitive impairment and cognitive decline?
Figure 5 shows the risk of cognitive impairment was similar 
to that for All and Dementia, but the risk for cognitive decline, 
which was measured in only 21 ratios from seven studies, did 
not remain significantly less than 1.0 (see CogImp [0.78] and 
CogDec [0.96]). The recent meta-analysis by Peters et al11 
also failed to find a significant benefit of alcohol use against 
cognitive decline (RR = 0.89; 95% CI: 0.67–1.17).
Do light, moderate, and heavy drinking  
have different effects on cognitive risk?
Both light and moderate drinking were associated with 
  significantly reduced cognitive risk, while heavy drinking 
was associated with increased cognitive risk, as seen in 
Figure 5 (light [0.75], mod [0.69, and heavy [1.13]]).
Do different types of alcohol (wine, beer,  
and spirits) affect cognitive risk in the same way?
Wine provided a significant reduction in cognitive risk, 
while beer and spirits did not, as seen in Figure 5 (wine 
[0.77], beer [1.05], and spirits [0.98]). Consistent with 
this finding, in the Washington Heights-Inwood Columbia 
Aging Project (WHICAP) cohort Luchsinger et al142 found 
a reduced risk (RR = 0.45) of AD only in those consum-
ing up to three daily servings of wine who also lacked 
the APOE ε4 allele; there was no significant reduction 
of risk in those consuming beer (RR = 1.47) and spirits 
(RR = 1.51). However, this conclusion must be qualified 
in two ways. First, it is based on a relatively small number 
of ratios from a small number of studies. Second, a number 
of studies explicitly looked for but did not find a difference 
between types of alcohol. For example, Huang et al125 found 
that light to moderate drinkers had a significantly reduced 
risk of developing dementia compared with nondrinkers 
(RR = 0.50), regardless of the type of alcohol consumed. 
Likewise, the Rotterdam Study129 found a significantly 
reduced risk (HR = 0.58) of dementia in moderate (#3 
drinks/day) drinkers of any type of alcohol. In addition, 
when Ruitenberg et al129 used the HR for dementia of wine 
drinkers as the reference (1.00), they found the HR for beer 
was 0.64 (95% CI: 0.25–1.61) and for spirits was 1.32 (95% 
CI: 0.77–2.26), yielding no significant differences between 
these types of alcohol. However, male and female drinkers 
were combined for this analysis, and the two sexes have dif-
ferent drinking patterns, which may have masked genuine 
differences among types of alcohol.160
Does the APOe ε4 allele alter the effect  
of alcohol on cognition?
The presence of the APOE ε4 allele appeared to eliminate 
the significantly reduced cognitive risk effect of moderate 
drinking, as seen for e4 (0.89) and noe4 (0.70) in Figure 5. 
Consistent with this conclusion, in the WHICAP cohort 
Luchsinger et al142 found a reduced risk (RR = 0.45) of AD 
only in those without the APOE ε4 allele who were drinking 
up to three daily servings of wine. Similarly, in Canada, 
Lindsay et al127 reported an increased risk (OR = 3.28) for 
AD for drinkers (any amount) with the APOE ε4 allele. 
Likewise, the study in Finland by Anttila et al139 found that 
infrequent (,1 drink/month) “binge” drinkers without the 
APOE ε4 had a nonsignificantly reduced risk of dementia 
(RR = 0.45) compared with nondrinkers, while infrequent 
“binge” drinkers with APOE ε4 had a large and significant 
increase in the risk of dementia (RR = 2.30). The same study 
reported an increased risk (OR = 7.07) for dementia in heavy 
(frequent) drinkers with the APOE ε4 allele. Furthermore, 
Harwood et al185 reported that those with the APOE ε4 allele 
have an earlier onset of AD by an average of 2.6 (for one ε4) 
or 5.3 (for two ε4s) years.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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In contrast, the Rotterdam Study129 reported the HR was 
reduced in subjects with the APOE ε4 allele, but the sample 
and the difference were both small. Likewise, Carmelli et al132 
found that light drinking (#1 drink/day) by white male 
veterans was associated with a significantly reduced risk 
(OR = 0.60) of poor cognitive function using the MMSE, 
particularly among those with the APOE ε4 allele. Similarly, 
Tanaka et al131 reported an OR of 1.60 (1.00, 2.55) for AD in 
moderate drinkers without the APOE ε4 allele.
Lastly, no effect of APOE ε4 was found in the Nurses’ 
Health Study147 in which women drinking moderately 
(1 drink/day) had a significantly reduced risk of cognitive 
decline (RR = 0.85), as measured by being in the worst 10% 
of the distribution of decline on the TICS.
In conclusion, although analysis found that the presence 
of APOE ε4 allele eliminated any significant “protective” 
effect of moderate ethanol on cognitive risk, a number of 
other studies have found an opposite effect and our results 
are based on a relatively small number of ratios from just ten 
studies, leaving this question unsettled.
Does the sex of the drinker alter the effect  
of alcohol on cognition?
There was no difference in alcohol’s effects between sexes, as 
seen in Figure 5 (male, 0.74; female, 0.69), despite the fact 
that men and women have very different drinking patterns. 
In general, male drinkers drink more than female drinkers 
and prefer beer and spirits, while female drinkers prefer 
wine.77,89,129,133,137,140
Does the effect of alcohol on cognition  
vary with country?
The beneficial association of moderate drinking with reduced 
cognitive risk was found in almost all countries studied 
(see Figure 6). These analyses were first done using all the 
ratios from each country, including ratios from heavy drink-
ers or those carrying the APOE ε4 allele. This “all ratios” 
approach found a significant benefit in the US (USA), the 
United Kingdom (UK), France, Italy, Spain, Germany, 
the   Netherlands, Sweden, Australia, Brazil, and Korea (as 
seen above the heavy dashed line running horizontally in 
  Figure 6), although for some countries (those below the 
same line in Figure 6) the approach failed to find a significant 
benefit. However, if ratios from heavy drinkers or those car-
rying the APOE ε4 allele were excluded, the country’s ratio 
then showed a significant benefit. For example, compare the 
canada and canada-ne4 (no ε4) lines, or the finland and finl-
ne4h (no ε4 and no heavy drinkers) lines. In Denmark the 
initial analysis (denmark) showed no benefit, but a benefit 
was seen if only wine drinkers were included (denmark-wn). 
Similarly, China and Taiwan (chinat) initially showed no 
significant benefit, but if heavy drinkers were excluded 
(chinat-nh) a significant benefit was found. However, this 
strategy did not succeed in identifying a significant benefit 
for Hungary (compare hungary and hungary-nh lines) or for 
Japan (compare japan and japan-nh lines). However, in the 
case of Japan it should be noted that two studies of Japanese 
Americans (japan-amer)114,148 did find a significant benefit of 
alcohol, suggesting failure to find a significant benefit in the 
studies in Japan may not have a genetic basis. In addition, 
one “no ratio” study of Japanese Americans found better 
cognition in moderate drinkers.79 No overall benefit was 
seen in two studies from Nigeria, although one of the studies 
did have an OR significantly lower than 1151 while the other 
did not150 (solid dots indicate these two ORs in Figure 6). 
Two studies of African-Americans did find nonsignificantly 
reduced risk in drinkers.135,151 Lastly, one study in Greece128 
reported a nonsignificantly reduced risk in drinkers.
The absence of studies from Eastern Europe and Rus-
sia is notable, but a 2009 paper with a large number of 
Russian authors stated: “To our knowledge, there are no 
published or ongoing population-based studies designed to 
estimate the prevalence of AD and other forms of dementia 
in Russia.”186
General discussion
Summary
The history of research on moderate drinking and cognition 
can be divided into two eras: 1977–1997 and 1998–present. 
Phase I (1977–1997) was the era of neuropsychological 
evaluation involving mostly young to middle-aged 
(18–50 years old) subjects. Although initial studies indi-
cated moderate drinking impaired cognition, many later 
studies failed to confirm this, instead finding no difference 
in cognition between drinkers and nondrinkers. Phase II 
(1998–present) was and is the era of mental status exam 
evaluation involving mostly older ($55 years old) subjects. 
These studies overwhelmingly found that moderate drinking 
either reduced or had no effect on the risk of dementia or 
cognitive impairment.
When all the ratios of risk from all the studies in phase II 
providing such ratios are entered into a comprehensive meta-
analysis, the average ratio of risk for cognitive risk (dementia 
or cognitive impairment/decline) associated with moderate 
“social” drinking of alcohol is 0.77, with nondrinkers as the 
reference group. This value is similar to the values obtained 
by two recent and much more selective meta-analyses (Anstey 
et al12 overall RR = 0.74; Peters et al11 overall RR = 0.73).   Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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The benefit of moderate drinking applied to all forms of 
dementia and to cognitive impairment, but no significant 
benefit against cognitive decline was found.
Both light and moderate drinking provided a similar benefit, 
but heavy drinking was associated with nonsignificantly higher 
cognitive risk for dementia and cognitive impairment.
Although the meta-analysis also indicated that wine was 
better than beer or spirits, this was based on a relatively small 
number of studies because most studies did not distinguish 
among these different types of alcohol. Furthermore, a number 
of the studies that did make this distinction reported no differ-
ence between the effects of these different types of alcohol. 
Therefore, at present this question remains unanswered.
Analysis also showed the presence of the APOE ε4 allele 
eliminated the benefit of moderate drinking. However, the 
analysis was based on a relatively small number of studies, 
and several other studies have found the opposite effect. 
Further studies are necessary to settle this question.
The benefit of moderate alcohol was seen in both men 
and women, although the pattern of drinking is very different 
between the two sexes, with male drinkers drinking much 
more than female drinkers and women tending to prefer wine 
over other forms of alcohol.129,160
Overall, light to moderate drinking does not appear to 
impair cognition in younger subjects and actually seems to 
reduce the risk of dementia and cognitive decline in older 
subjects. This basic finding was the same in many different 
countries, particularly when results from heavy drinkers or 
subjects with the APOE ε4 allele were excluded.
Mental status exams
The MMSE,187 which has been the “workhorse” of the 
mental status era, is considered to have several weaknesses, 
including relatively poor assessment of executive function 
and floor and ceiling effects because it has only 30 possible 
points.188,189 These limitations were reviewed in a recent 
meta-analysis of the MMSE, which concluded it was best 
for “ruling-out a diagnosis of dementia in community and 
primary care” and that “for all other uses it should be com-
bined with or replaced by other methods.”190 Nonetheless, 
the very fact of the MMSE’s widespread use means that “the 
same ruler” has been applied to measuring cognition in many 
studies, making the consistent results of a benefit of moderate 
drinking plausible. In addition, in about 60% of the 67 studies 
with and without ratios that used some type of mental sta-
tus exam, the status exam was combined with one or more 
Ratio of risk (drinkers/nondrinkers)
Greece n =1 (1) 0.56 (0.26, 1.21)
Afr-Amer n = 2 (2) 0.68 (0.39, 1.21)
Nigeria n = 2 (2) 1.36 (0.60, 3.09)
Japan-Amer n = 4 (2) 0.67 (0.55, 0.81)
Japan-nh n = 5 (3) 1.09 (0.60, 1.98)
Japan n = 9 (3) 1.21 (0.89, 1.64)
Hungary-nh n = 1 (1) 0.90 (0.70, 1.30)
Hungary n = 2 (1) 1.24 (0.63, 2.43)
Chinat-nh n = 21 (5) 0.65 (0.47, 0.89)
Chinat n = 35 (5) 0.91 (0.70, 1.19)
Denmark-wn n = 3 (1) 0.42 (0.26, 0.68)
Denmark n = 12 (1) 1.07 (0.74, 1.52)
Finl-ne4 h n = 13 (4) 0.77 (0.57, 1.04)
Finland n = 31 (4) 1.22 (0.95, 1.57)
Canada-ne4 n = 4 (1) 0.70 (0.56, 0.88)
Canada n = 11 (3) 0.91 (0.56, 1.46)
Korea n = 8 (1) 0.49 (0.39, 0.63)
Brazil n = 8 (1) 0.67 (0.49, 0.93)
Australia n = 11 (3) 0.61 (0.54, 0.71)
Sweden n = 8 (2) 0.63 (0.48, 0.84)
Holland n = 39 (2) 0.63 (0.54, 0.74)
Germany n = 19 (2) 0.68 (0.60, 0.77)
Spain n = 18 (2) 0.64 (0.49, 0.82)
Italy n = 31 (4) 0.79 (0.67, 0.94)
France n = 23 (5) 0.73 (0.61 ,0.88)
UK n = 18 (5) 0.75 (0.68, 0.82)
USA n = 159(27) 0.77 (0.73, 0.81)
All n = 446 (74) 0.77 (0.73, 0.80)
Geography: Moderate drinking and risk of dementia or cognitive impairment/decline
0.00 0.25 0.50 0.75 1.00 1.25 1.50 2.00 2.50 3.00
Figure 6 Overall weighted mean ratios (XRwm) comparing cognitive risk in drinkers and nondrinkers by country. Country with number of ratios (number of studies) indicated 
on left; XRwm (95% confidence interval) given on right.
Abbreviations: afr-amer, African-Americans; australia, Australia; brazil, Brazil; canada, Canada; canada-ne4, Canada, no epsilon 4; chinat, China and Taiwan; chinat-nh, China 
and Taiwan, no heavy drinkers; denmark, Denmark; denmark-wn, Denmark, wine drinkers; finland, Finland; finl-ne4h, Finland, no epsilon 4, no heavy drinkers; france, France; 
germany, Germany; greece, Greece; holland, the Netherlands; hungary, Hungary; hungary-nh, Hungary, no heavy drinkers; italy, italy; japan, Japan; japan-amer, Japanese 
Americans; japan-nh, Japan, no heavy drinkers; korea, Korea; nigeria, Nigeria; spain, Spain; sweden, Sweden; UK, United Kingdom; USA, United States of America; XR, hazard 
ratio, odds ratio, and risk ratio.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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other measurements of cognition, making the judgment of 
dementia or cognitive impairment more reliable.
Comparison with other cognitive  
risk reducers
How does an overall ratio of 0.77 compare with ratios of 
risk associated with other “treatments” or activities that 
have shown some benefit against dementia and cognitive 
decline? Those who eat a Mediterranean diet – which 
includes high intake of vegetables, fruits, cereals, fish, olive 
oil, and wine – have an OR for dementia of 0.60.191 Similarly, 
Gu et al192 reported that the HR for AD was 0.62 (95% CI: 
0.43–0.89) after multivariable adjustment for subjects in the 
highest third of conformity to a specific dietary pattern associ-
ated with reduced AD risk. Likewise, more years of education 
and the associated fuller participation in social and intellec-
tual life193 provide a benefit of similar magnitude (overall 
RR of 0.84), perhaps by producing a “cognitive reserve” 
that results in a more gradual rate of cognitive decline.194 
  Gardening has also been associated with a reduced risk 
(HR = 0.64) of AD.152 Therefore, the reduced cognitive 
risk from moderate drinking is similar in size to the reduced 
risk associated with other factors.
Other beneficial outcomes  
of moderate drinking
Mukamal et al195 found that low to moderate alcohol 
  consumption (5–30 g/day) further reduced the risk (OR = 0.38; 
95% CI: 0.16–0.89) of myocardial infarction in men (8867 
subjects), even if they were also nonsmokers who were 
active $30 min/day and had a body mass index of ,25. 
Similarly, in the Healthy Aging: a Longitudinal study in 
Europe project, low to moderate alcohol consumption was 
found to have a similarly beneficial effect on risk of mortality 
(HR = 0.78) to a Mediterranean diet (HR = 0.77), physical 
activity (HR = 0.63), and nonsmoking (HR = 0.65), with the 
combination of all four beneficial factors reducing the risk of 
mortality to 0.35.196 Imhof et al197 found that low to moderate 
drinking reduced a variety of biomarkers of inflammation, 
including C-reactive protein, fibrinogen, white blood cell 
count, and plasma viscosity. Britton et al198 found that a cardio-
protective benefit of moderate drinking was found among those 
with poor health behaviors (little exercise, poor diet, and smok-
ing), but no additional cardioprotective benefit of alcohol was 
found in those with the healthiest behavior profile. French and 
Zavala199 found that current moderate drinkers had the highest 
odds (OR = 1.27 for men, OR = 2.03 for women) of report-
ing above-average health status compared with nondrinkers. 
Karlamangla et al200 found that light to moderate drinking was 
associated with a reduced risk for incident disability or death 
over 5 years compared with abstention (OR = 0.77). Tien 
et al201 found that low to moderate blood alcohol level at the 
time of a traumatic brain injury is associated with reduced risk 
of mortality (OR = 0.76; 95% CI: 0.52–0.98). Overall, then, 
the reduced cognitive risk associated with moderate drinking 
is comparable with the reduced risk for death, cardiovascular 
disease, and other morbidities.
Conclusion
Heavy drinking (.3–4 drinks/day) is associated with an 
increased risk of dementia and cognitive impairment, in 
addition to all the other horrible and devastating   consequences 
of alcohol abuse and alcoholism for the individual and their 
family and friends, and society in general.   However, light 
to moderate drinking (#2 drinks/day for men, #1 drink/day 
for women) by adults does not increase the risk of dementia, 
cognitive decline, or cognitive impairment – a conclusion 
also reached by a recent comprehensive review.13 In fact, 
notwithstanding the conclusion in a recent article that “no 
evidence of even moderate scientific quality exists to support 
the association of any modifiable factor … with reduced 
risk for Alzheimer disease,”202 there is substantial evidence 
that light to moderate drinking (as defined in the National 
Institute on Alcohol Abuse and Alcoholism’s position paper 
on moderate drinking203), particularly of wine, reduces the 
risk of dementia and cognitive impairment.
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